In liver cancer, the limitation of glutamine in the TME results in diminished GLS2 expression within CD8+ T cells, consequently triggering ER stress and impairing the cytotoxic T cells’ capacity to eliminate cancer cells (88). This evidence concerns the gene CD8A and cancer.